Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

CONTEXT: Younger age at treatment onset with conventional therapy (phosphate salts and active vitamin D; Pi/D) is associated with improved growth and skeletal outcomes in children with X-linked hypophosphatemia (XLH). The effect of age on burosumab efficacy and safety in XLH is unknown. OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Leanne M, Glorieux, Francis H, Whyte, Michael P, Munns, Craig F, Portale, Anthony A, Högler, Wolfgang, Simmons, Jill H, Gottesman, Gary S, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Nilsson, Ola, Mao, Meng, Chen, Angel, Skrinar, Alison, Roberts, Mary Scott, Imel, Erik A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282253/
https://www.ncbi.nlm.nih.gov/pubmed/35533340
http://dx.doi.org/10.1210/clinem/dgac296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282253/
https://www.ncbi.nlm.nih.gov/pubmed/35533340
http://dx.doi.org/10.1210/clinem/dgac296

Ejemplares similares